|
ZNF565 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.723500E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.332000E-02 |
| Normal-vs-Stage2 |
5.070000E-01 |
| Normal-vs-Stage3 |
1.817740E-02 |
| Normal-vs-Stage4 |
6.299600E-01 |
| Stage1-vs-Stage2 |
5.121600E-01 |
| Stage1-vs-Stage3 |
4.337400E-01 |
| Stage1-vs-Stage4 |
9.217200E-01 |
| Stage2-vs-Stage3 |
2.908600E-01 |
| Stage2-vs-Stage4 |
8.555400E-01 |
| Stage3-vs-Stage4 |
7.234600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.293900E-02 |
| Normal-vs-AfricanAmerican |
3.361600E-02 |
| Normal-vs-Asian |
3.634600E-01 |
| Caucasian-vs-AfricanAmerican |
4.476400E-01 |
| Caucasian-vs-Asian |
9.972600E-01 |
| AfricanAmerican-vs-Asian |
7.930400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.338600E-03 |
| Normal-vs-Female |
9.299200E-01 |
| Male-vs-Female |
9.200100E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.301400E-01 |
| Normal-vs-Extreme_Weight |
6.479100E-03 |
| Normal-vs-Obese |
1.914980E-01 |
| Normal-vs-Extreme_Obese |
1.761450E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.524800E-01 |
| Normal_Weight-vs-Obese |
9.883200E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.800600E-01 |
| Extreme_Weight-vs-Obese |
1.071570E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.299600E-01 |
| Obese-vs-Extreme_Obese |
7.215200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.335800E-01 |
| Normal-vs-Age(41-60Yrs) |
3.111200E-01 |
| Normal-vs-Age(61-80Yrs) |
1.053870E-02 |
| Normal-vs-Age(81-100Yrs) |
7.401600E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.666200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.893200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.893600E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.828200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.771900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.429200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.097900E-02 |
| Normal-VS-Type2 PRCC |
1.141010E-03 |
| Normal-VS-KIRP CIMP |
1.636820E-01 |
| Normal-VS-Unclassified PRCC |
3.230200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.644200E-02 |
| Type1 PRCC-VS-KIRP CIMP |
8.220200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.636200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.019400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.148210E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.416400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.577700E-02 |
| Normal-vs-N1 |
7.544600E-01 |
| Normal-vs-N2 |
5.074100E-02 |
| N0-vs-N1 |
3.806800E-01 |
| N0-vs-N2 |
4.944800E-01 |
| N1-vs-N2 |
4.528800E-01 |
|
|
